Edwards Lifesciences | EW

Stock Price
80.94
Daily Change
-0.02 -0.02%
Monthly
2.96%
Yearly
21.19%
Q3 Forecast
80.27

Peers Price Chg Day Year Date
Abbott 132.94 0.13 0.10% 16.68% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
ICU Medical 131.24 5.61 4.47% -19.15% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05
US400 3297 16.31 0.50% 12.16% Sep/05

Edwards Lifesciences traded at $80.94 this Friday September 5th, decreasing $0.02 or 0.02 percent since the previous trading session. Looking back, over the last four weeks, Edwards Lifesciences lost 2.96 percent. Over the last 12 months, its price rose by 21.19 percent. Looking ahead, we forecast Edwards Lifesciences to be priced at 80.27 by the end of this quarter and at 78.29 in one year, according to Trading Economics global macro models projections and analysts expectations.

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.